These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


130 related items for PubMed ID: 8185889

  • 41. Activities of the frog skin peptide, ascaphin-8 and its lysine-substituted analogs against clinical isolates of extended-spectrum beta-lactamase (ESBL) producing bacteria.
    Eley A, Ibrahim M, Kurdi SE, Conlon JM.
    Peptides; 2008 Jan; 29(1):25-30. PubMed ID: 18068868
    [Abstract] [Full Text] [Related]

  • 42. Heterogeneous resistance to vancomycin in Staphylococcus epidermidis, Staphylococcus haemolyticus and Staphylococcus warneri clinical strains: characterisation of glycopeptide susceptibility profiles and cell wall thickening.
    Nunes AP, Teixeira LM, Iorio NL, Bastos CC, de Sousa Fonseca L, Souto-Padrón T, dos Santos KR.
    Int J Antimicrob Agents; 2006 Apr; 27(4):307-15. PubMed ID: 16542825
    [Abstract] [Full Text] [Related]

  • 43.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Identification of Staphylococcus epidermidis and Staphylococcus hominis from blood cultures by testing susceptibility to desferrioxamine.
    Lindsay JA, Aravena-Román MA, Riley TV.
    Eur J Clin Microbiol Infect Dis; 1993 Feb; 12(2):127-31. PubMed ID: 8500481
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49. Inhibition of bacterial multiplication by the iron chelator deferoxamine: potentiating effect of ascorbic acid.
    van Asbeck BS, Marcelis JH, Marx JJ, Struyvenberg A, van Kats JH, Verhoef J.
    Eur J Clin Microbiol; 1983 Oct; 2(5):426-31. PubMed ID: 6416837
    [Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51. Potentiation of the in vitro activity of some antimicrobial agents against selected gram-negative bacteria by EDTA-tromethamine.
    Farca AM, Nebbia P, Re G.
    Vet Res Commun; 1993 Oct; 17(2):77-84. PubMed ID: 8212526
    [Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54. Susceptibility to desferrioxamine: a new test for the identification of Staphylococcus epidermidis.
    Lindsay JA, Riley TV.
    J Med Microbiol; 1991 Jul; 35(1):45-8. PubMed ID: 2072377
    [Abstract] [Full Text] [Related]

  • 55. [In vitro sensibility of 1480 bacterial strains isolated from premature infants to gentamicin].
    Cocchi P, Mori S, Calandi C.
    G Ital Chemioter; 1969 Jul; 16(1):34-7. PubMed ID: 4998306
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58. [Interpretation of the influence of immunoglobulins and glycine on bacterial sensitivity to antibiotics in vitro].
    Gillissen G, Melzer B, Breuer-Werle M.
    Pathol Biol (Paris); 1989 May; 37(5):341-5. PubMed ID: 2674866
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 7.